| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.34B | — | +16.3% |
| Cost of Revenue | $7.56B | — | +15.2% |
| Gross Profit | $1.78B | — | +21.2% |
| R&D Expense | $304.0M | — | +27.2% |
| SG&A Expense | $1.30B | — | +9.3% |
| Operating Income | $179.0M | — | +316.3% |
| Pre-tax Income | $5.10B | — | +1437.0% |
| Income Tax | $354.0M | — | +420.6% |
| Net Income | $4.75B | — | +1768.1% |
| EPS (Basic) | $17.65 | — | +1818.5% |
| EPS (Diluted) | $17.44 | — | +1816.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $9.57B | -2.4% | +34.1% |
| Inventory | $11.92B | +14.3% | +30.2% |
| Current Assets | $42.97B | +6.8% | +26.6% |
| Total Assets | $75.61B | +20.0% | +46.7% |
| Current Liabilities | $48.09B | +17.4% | +47.2% |
| Long-term Debt | $2.81B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.19B | — | +346.9% |
| Investing Cash Flow | -$4.29B | — | -4514.0% |
| Financing Cash Flow | $442.0M | — | +135.2% |
| — |
| Total Liabilities | $60.55B | +19.4% | +44.5% |
| Stockholders' Equity | $13.92B | +24.5% | +61.8% |